SpringerLink
Log in

Decentralized investor communities gain traction in biotech

  • News Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Despite its checkered reputation, cryptocurrency is being considered by a handful of academics as a means to funnel funds into translational research. Is the trend likely to spread? Laura DeFrancesco and Ariel Klevecz investigate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: VitaDAO ecosystem.

Author information

Authors and Affiliations

  1. Senior Editor, Nature Biotechnology https://www.nature.com/nbt/

    Laura DeFrancesco

  2. Los Angeles, CA, USA

    Ariel Klevecz

Authors
  1. Laura DeFrancesco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ariel Klevecz
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

A.K. is a member of two DAOs, Myosin and Hifi.Labs.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

DeFrancesco, L., Klevecz, A. Decentralized investor communities gain traction in biotech. Nat Biotechnol 40, 1310–1315 (2022). https://doi.org/10.1038/s41587-022-01459-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-022-01459-z

  • Springer Nature America, Inc.

Search

Navigation